Acorda Gets Interim OK For $60M DIP With $40M Rollup
Acorda Therapeutics Inc., a developer of drug treatments for neurological disorders, received on Thursday interim approval to access $10 million of a $60 million debtor-in-possession loan package from a group of...To view the full article, register now.
Already a subscriber? Click here to view full article